Institutional investors purchased a net $3.8 million shares of TSRO during the quarter ended December 2016 and now own 85.86% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 1.5 Million shares of TESARO Inc
FRANKLIN ADVISERS, INC. Bought 534.7 Thousand shares of TESARO Inc